World Neurosurg
-
To investigate the possible influence of risk factors on seizure outcome after surgery for drug-resistant nonlesional temporal lobe epilepsy (TLE). ⋯ Many patients with drug-resistant nonlesional TLE responded favorably to surgery. The only factor predictive of seizure outcome after surgery was a history of febrile seizure in childhood. It is critical to distinguish among different types of TLE when assessing outcome after surgery.
-
Observational Study
Solitary sporadic cerebral cavernous malformations (CCM)- Risk factors of first or recurrent symptomatic hemorrhage and associated functional impairment.
To quantify the risk of a first or recurrent hemorrhage and the associated functional impairment in patients with sporadic solitary cerebral cavernous malformations (CCMs) and to investigate the potential risk factors. ⋯ This study provides an estimate of symptomatic hemorrhage risk and the associated disability in patients with sporadic solitary CCM and an investigation of risk factors.
-
Proposal and Validation of a Basic Progression Scoring System for Patients with Skull Base Chordoma.
To propose and further validate a basic progression scoring system for patients with skull base chordoma. ⋯ The basic progression scoring system for patients with skull base chordoma is valid and reproducible.
-
Reducing complications from unruptured aneurysms (UAs) treatment is important. We clarify the criteria for achieving safe and complete treatment for UAs ≤10 mm by clipping or coil embolization. ⋯ The treatment for UAs within the criteria, with the most recent points of concern, can lead to safe and complete results.
-
Giant pituitary adenoma (>4 cm) remains challenging because the optimal surgical approach is uncertain. ⋯ In this series of giant pituitary adenoma, primary (ie, the first) ETTS yielded complete resection and cure in 21.1%. Along with adjuvant therapies, including GKRS, most patients (97.4%) were stable and free of disease progression. Therefore, primary ETTS appeared to be an effective surgical approach for giant pituitary adenoma.